Evaluation of chondrocyte death in canine osteochondral explants exposed to a 0.5% solution of bupivacaine

American Journal of Veterinary Research

Volumn 71, Issue 8, 2010, Pages 875-883

  Hennig, Geoffrey S ^a   Hosgood, Giselle ^b   Bubenik Angapen, Loretta J ^c   Lauer, Susanne K ^a   Morgan, Timothy W ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b MURDOCH UNIVERSITY   (Australia)

^c Sugar Land Product Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPIVACAINE; METHYL PARABEN; 4 HYDROXYBENZOIC ACID ESTER; LOCAL ANESTHETIC AGENT;

ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; CADAVER; CARTILAGE CELL; CONTROLLED STUDY; CULTURE MEDIUM; DEBRIDEMENT; DOG; DRUG CYTOTOXICITY; EXPLANT; HISTOLOGY; HUMERUS; JOINT; LOCAL ANESTHESIA; NONHUMAN; SHOULDER; SYNOVIUM; ANIMAL; CARTILAGE; CELL DEATH; CYTOLOGY; DRUG EFFECT; KINETICS;

ANESTHETICS, LOCAL; ANIMALS; BUPIVACAINE; CADAVER; CARTILAGE; CELL DEATH; CHONDROCYTES; DOGS; HUMERUS; KINETICS; PARABENS;

EID: 77956834967     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.71.8.875     Document Type: Article

References (52)

1. Hoelzler MG, Harvey RC, Lidbetter DA, et al. Comparison of perioperative analgesic protocols for dogs undergoing tibial plateau leveling osteotomy. Vet Surg 2005;34:337-344.
2. Sammarco JL, Conzemius MG, Perkowski SZ, et al. Postoperative analgesia for stifle surgery: a comparison of intra-articular bupivacaine, morphine, or saline. Vet Surg 1996;25:59-69. (Pubitemid 126732228)
3. Heard SO, Edwards WT, Ferrari D, et al. Analgesic effect of intraarticular bupivacaine or morphine after arthroscopic knee surgery: a randomized, prospective, double-blind study. Anesth Analg 1992;74:822-826.
4. Reuben SS, Sklar J. Pain management in patients who undergo outpatient arthroscopic surgery of the knee. J Bone Joint Surg Am 2000;82:1754-1766.
5. Chao D, Young S, Cawley P. Postoperative pain management for arthroscopic shoulder surgery: interscalene block versus patient-controlled infusion of 0.25% bupivicaine. Am J Orthop 2006;35:231-234.
6. Ciccone II WJ, Busey TD, Weinstein DM, et al. Assessment of pain relief provided by interscalene regional block and infusion pump after arthroscopic shoulder surgery. Arthroscopy 2008;24:14-19.
7. Shafford HL, Hellyer PW, Turner AS. Intra-articular lidocaine plus bupivacaine in sheep undergoing stifle arthrotomy. Vet Anaesth Analg 2004;31:20-26.
8. Muir WW, Hubbell JAE, Skarda R. Local anesthesia in dogs and cats. In: Muir WW, Hubbell JAE, Skarda R, et al, eds. Handbook of veterinary anesthesia. 3rd ed. St Louis: Mosby Inc, 2000;100-118.
9. Reichert MG, Butterworth J. Local anesthetic additives to increase stability and prevent organism growth. Tech Reg Anesth Pain Manage 2004;8:106-109. (Pubitemid 39422426)
10. Nole R, Munson NM, Fulkerson JP. Bupivacaine and saline effects on articular cartilage. Arthroscopy 1985;1:123-127. (Pubitemid 15024129)
11. Fulkerson JP, Winters TF Jr. Articular cartilage response to arthroscopic surgery: a review of current knowledge. Arthroscopy 1986;2:184-189.
12. Jones TA, Hand WR Jr, Ports MD, et al. An evaluation of the histological effects of intra-articular methadone in the canine model. AANA J 2003;71:51-54.
13. Petty DH, Jazrawi LM, Estrada LS, et al. Glenohumeral chondrolysis after shoulder arthroscopy: case reports and review of the literature. Am J Sports Med 2004;32:509-515. (Pubitemid 38235525)
14. Bojescul JA, Wilson G, Taylor DC. Idiopathic chondrolysis of the ankle. Arthroscopy 2005;21:224-227.
15. Hansen BP, Beck CL, Beck EP, et al. Postarthroscopic glenohumeral chondrolysis. Am J Sports Med 2007;35:1628-1634.
16. Chu CR, Izzo NJ, Coyle CH, et al. The in vitro effects of bupivacaine on articular chondrocytes. J Bone Joint Surg Br 2008;90:814-820. (Pubitemid 351859815)
17. Piper SL, Kim HT. Comparison of ropivacaine and bupivacaine toxicity in human articular chondrocytes. J Bone Joint Surg Am 2008;90:986-991.
18. Chu CR, Izzo NJ, Papas NE, et al. In vitro exposure to 0.5% bupivacaine is cytotoxic to bovine articular chondrocytes. Arthroscopy 2006;22:693-699.
19. Anz A, Smith MJ, Stoker A, et al. The effect of bupivacaine and morphine in a coculture model of diarthrodial joints. Arthroscopy 2009;25:225-231.
20. Gomoll AH, Kang RW, Williams JM, et al. Chondrolysis after continuous intra-articular bupivacaine infusion: an experimental model investigating chondrotoxicity in the rabbit shoulder. Arthroscopy 2006;22:813-819.
21. Dogan N, Erdem AF, Erman Z, et al. The effects of bupivacaine and neostigmine on articular cartilage and synovium in the rabbit knee joint. J Int Med Res 2004;32:513-519. (Pubitemid 39255596)
22. Goldring MB. The role of the chondrocyte in osteoarthritis. Arthritis Rheum 2000;43:1916-1926.
23. Athanasiou KA, Rosenwasser MP, Buckwalter JA, et al. Interspecies comparisons of in situ intrinsic mechanical properties of distal femoral cartilage. J Orthop Res 1991;9:330-340.
24. Mankin HJ, Dorfman H, Lippiello L, et al. Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am 1971;53:523-537.
25. Irwin MG, Cheung KM, Nicholls JM, et al. Intra-articular injection of ketorolac in the rat knee joint: effect on articular cartilage and synovium. Br J Anaesth 1998;80:837-839.
26. Brakenhoff GJ, van der Voort HT, van Spronsen EA, et al. Three-dimensional imaging in fluorescence by confocal scanning microscopy. J Microsc 1989;153:151-159.
27. Agresti A. Generalized Cochran-Mantel-Haenszel test. In: An introduction to categorical analysis. New York: John Wiley and Sons, 1996;188-190.
28. Paatsama S, Rokkanen P, Jussila J, et al. A study of osteochondritis dissecans of the canine humeral head using histological, OTC bone labelling, microradiographic and microangiographic methods. J Small Anim Pract 1971;12:603-611.
29. Guilak F, Ratcliffe A, Lane N, et al. Mechanical and biochemical changes in the superficial zone of articular cartilage in canine experimental osteoarthritis. J Orthop Res 1994;12:474-484. (Pubitemid 24266641)
30. Furman BD, Olson SA, Guilak F. The development of posttraumatic arthritis after articular fracture. J Orthop Trauma 2006;20:719-725.
31. Roy RG, Wallace LJ, Johnston GR, et al. A retrospective evaluation of stifle osteoarthritis in dogs with bilateral medial patellar luxation and unilateral surgical repair. Vet Surg 1992;21:475-479.
32. Bubenik L, Hosgood G, Barker S, et al. Estimated plasma bupivacaine concentration after single dose and eight-hour continuous intra-articular infusion of bupivacaine in normal dogs. Vet Surg 2007;36:783-791. (Pubitemid 350209554)
33. Soni MG, Taylor SL, Greenberg NA, et al. Evaluation of the health aspects of methyl paraben: a review of the published literature. Food Chem Toxicol 2002;40:1335-1373.
34. Nagel JE, Fuscaldo JT, Fireman P. Paraben allergy. JAMA 1977;237:1594-1595.
35. Adams ME, Billingham ME. Animal models of degenerative joint disease. Curr Top Pathol 1982;71:265-297.
36. Pond MJ, Nuki G. Experimentally-induced osteoarthritis in the dog. Ann Rheum Dis 1973;32:387-388.
37. Cummings NA, Nordby GL. Measurement of synovial fluid pH in normal and arthritic knees. Arthritis Rheum 1966;9:47-56.
38. Karpie JC, Chu CR. Lidocaine exhibits dose- and time-dependent cytotoxic effects on bovine articular chondrocytes in vitro. Am J Sports Med 2007;35:1621-1627.
39. Dahl MR, Dasta JF, Zuelzer W, et al. Lidocaine local anesthesia for arthroscopic knee surgery. Anesth Analg 1990;71:670-674.
40. Miskulin M, Maldini B. Outpatient arthroscopic knee surgery under multimodal analgesic regimens. Arthroscopy 2006;22:978-983. (Pubitemid 44301784)
41. Convery PN, Milligan KR, Quinn P, et al. Efficacy and uptake of ropivacaine and bupivacaine after single intra-articular injection in the knee joint. Br J Anaesth 2001;87:570-576. (Pubitemid 32936734)
42. Samoladas EP, Chalidis B, Fotiadis H, et al. The intra-articular use of ropivacaine for the control of post knee arthroscopy pain. J Orthop Surg (Hong Kong) 2006;1:17.
43. McLure HA, Rubin AP. Review of local anaesthetic agents. Minerva Anestesiol 2005;71:59-74.
44. Scott DB, Lee A, Fagan D, et al. Acute toxicity of ropivacaine compared with that of bupivacaine. Anesth Analg 1989;69:563-569. (Pubitemid 20043242)
45. Knudsen K, Beckman Suurkula M, Blomberg S, et al. Central nervous and cardiovascular effects of i.v. infusions of ropivacaine, bupivacaine and placebo in volunteers. Br J Anaesth 1997;78:507-514. (Pubitemid 27226361)
46. Bolt DM, Ishihara A, Weisbrode SE, et al. Effects of triamcinolone acetonide, sodium hyaluronate, amikacin sulfate, and mepivacaine hydrochloride, alone and in combination, on morphology and matrix composition of lipopolysaccharide-challenged and unchallenged equine articular cartilage explants. Am J Vet Res 2008;69:861-867.
47. Feinstein DL, Murphy P, Sharp A, et al. Local anesthetics potentiate nitric oxide synthase type 2 expression in rat glial cells. J Neurosurg Anesthesiol 2001;13:99-105. (Pubitemid 32244985)
48. Kamath R, Strichartz G, Rosenthal D. Perspective: cartilage toxicity from local anesthetics. Skeletal Radiol 2008;37:871-873.
49. Chiang N, Schwab JM, Fredman G, et al. Anesthetics impact the resolution of inflammation. PLoS ONE 2008;3:e1879.
50. Park CJ, Park SA, Yoon TG, et al. Bupivacaine induces apoptosis via ROS in the Schwann cell line. J Dent Res 2005;84:852-857.
51. Grouselle M, Tueux O, Dabadie P, et al. Effect of local anaesthetics on mitochondrial membrane potential in living cells. Biochem J 1990;271:269-272. (Pubitemid 20331229)
52. Irwin W, Fontaine E, Agnolucci L, et al. Bupivacaine myotoxicity is mediated by mitochondria. J Biol Chem 2002;277:12221-12227.